[Molecular therapy for HCC?]

MeSH terms

• Administration, Oral
• Adult
• Aged
• Aged, 80 and over
• Carcinoma, Hepatocellular / drug therapy*
• Carcinoma, Hepatocellular / mortality
• Carcinoma, Hepatocellular / pathology*
• Clinical Trials as Topic
• Confidence Intervals
• Dose-Response Relationship, Drug
• Drug Administration Schedule
• Erlotinib Hydrochloride
• Female
• Follow-Up Studies
• Humans
• Liver Neoplasms / drug therapy*
• Liver Neoplasms / mortality
• Liver Neoplasms / pathology*
• Male
• Maximum Tolerated Dose
• Middle Aged
• Neoplasm Invasiveness / pathology*
• Neoplasm Staging
• Probability
• Protein Kinase Inhibitors / administration & dosage
• Protein Kinase Inhibitors / adverse effects
• Quinazolines / administration & dosage*
• Quinazolines / adverse effects
• Survival Analysis
• Treatment Outcome